Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB1 | P15086 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13241284 | 0.78 | KDM4E (0.33) | CPB1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL1106833 | 0.77 | LMNA (0.48) | CPB1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL7798008 | 0.75 | CPB1 (0.56) | CPB1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL12132164 | 0.74 | CPB1 (0.45) | CPB1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL10933514 | 0.73 | CPB1 (0.62) | CPB1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL13241288 | 0.71 | CPB1 (0.51) | CPB1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL1106832 | 0.71 | CPB1 (0.61) | CPB1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL8684475 | 0.69 | HRH3 (0.50) | ALDH1A1KDM4EL3MBTL1HRH3 | |
| SCHEMBL28777931 | 0.67 | CPB1 (0.50) | CPB1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL17171976 | 0.67 | CPB1 (0.51) | CPB1ALDH1A1KDM4EPOLBNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8153716-B2 | Dispersant for an aqueous dispersion of positively charged or chargeable solid particulates which comprises a compound having an anchoring moiety linked to a polymeric hydrophilic moiety; inkjet recording element | EASTMAN KODAK COMPANY (US) | 2012-04-10 | — | — | US | disclosed |
| US-8063132-B2 | Coating composition comprising boehmite particles and one or more dispersants and a method of coating a substrate using said coating composition | EASTMAN KODAK COMPANY (US) | 2011-11-22 | — | — | US | disclosed |
| US-20080145546-A1 | Dispersant For Reducing Viscosity Of Particulate Solids | FPC INC. | 2008-06-19 | — | — | US | disclosed |
| US-20080090012-A1 | Aqueous boehmite particles of a hydrophilic polymer having a linked anchoring moiety which contains acid(s) and/or hydroxy(s); the polymeric moiety has a lower affinity for a boehmite surface than the anchoring moiety; mercaptosuccinic acid-modified polyacrylamide; ink jet; paper coating; gloss porousity | KODAK PHILIPPINES LTD. | 2008-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080090012-A1 | Aqueous boehmite particles of a hydrophilic polymer having a linked anchoring moiety which contains acid(s) and/or hydroxy(s); the polymeric moiety has a lower affinity for a boehmite surface than the anchoring moiety; mercaptosuccinic acid-modified polyacrylamide; ink jet; paper coating; gloss porousity | CD44, MPST, BHMT2 | CPB1 4252/4885ALDH1A1 320/4885KDM4E 1517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.